share_log
Benzinga ·  04/30 12:01

Harmony Biosciences Holdings Shares Are Trading Higher After the Company Reported Better-than-expected Q1 Adjusted EPS Results. The Company Acquired Epygenix Therapeutics

Harmony Biosciences Holdings公布的第一季度调整后每股收益好于预期后,该公司股价走高。该公司收购了Epygenix Therapeutics

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发